Medicus Pharma Ltd. (MDCX)

Medicus Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	20.69	17.92	7.65	4.54	0.33
Research & Development	17.14	16.44	3.53	0.19	0.65
Total Operating Expenses	37.83	34.36	11.18	4.73	0.98
Operating Income	-37.83	-34.36	-11.18	-4.73	-0.98
Interest Income	0.06	-	-	-	-
Interest Expense	-0.37	-	-	-	-
Other Non-Operating Income (Expense)	-1.24	-1.09	-0.03	-0.58	-0.71
Total Non-Operating Income (Expense)	-1.55	-1.09	-0.03	-0.58	-0.71
Pretax Income	-39.38	-35.44	-11.21	-5.31	-1.69
Net Income	-45.05	-47.28	-11.16	-5.31	-1.69
Minority Interest in Earnings	-0	-0	-	-	-
Net Income Attributable to Preferred Dividends	11.84	11.84	-	-	-
Net Income to Common	-45.05	-47.28	-11.16	-5.31	-1.69
Shares Outstanding (Basic)	20	17	10	3	2
Shares Outstanding (Diluted)	20	17	10	3	2
Shares Change (YoY)	96.32%	79.68%	176.45%	84.60%	-
EPS (Basic)	-2.69	-2.74	-1.16	-1.53	-0.90
EPS (Diluted)	-2.69	-2.74	-1.16	-1.53	-0.90
Shares Outstanding	40	25.18	11.82	8.08	1.88
Free Cash Flow	-27.81	-22.78	-10.25	-4.16	-1.06
Free Cash Flow Per Share	-1.37	-1.32	-1.07	-1.20	-0.56
EBITDA	-37.83	-34.36	-11.18	-4.73	-0.98
EBIT	-37.83	-34.36	-11.18	-4.73	-0.98

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q